Status:
ACTIVE_NOT_RECRUITING
Kebele Elimination of Trachoma for Ocular Health
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
National Eye Institute (NEI)
Eyu-Ethiopia
Conditions:
Trachoma
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
The investigators propose a cluster-randomized clinical trial to determine whether an intensive, targeted azithromycin distribution strategy is effective for elimination of trachoma at the kebele leve...
Detailed Description
The investigators propose to randomize at the kebele level, which consist of approximately 15 villages, 4,000 residents, and are served by a single primary school. Eighty kebeles will be randomized to...
Eligibility Criteria
Inclusion
- All individuals in all communities will be eligible for annual mass azithromycin distribution per WHO guidelines.
Exclusion
- Those who do not consent.
Key Trial Info
Start Date :
February 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2028
Estimated Enrollment :
320000 Patients enrolled
Trial Details
Trial ID
NCT03335072
Start Date
February 7 2022
End Date
March 1 2028
Last Update
October 23 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSF Proctor Foundation
San Francisco, California, United States, 94143
2
Eyu-Ethiopia
Bahir Dar, Ethiopia